Novel biomarkers and strategies for HCC diagnosis and care-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel biomarkers and strategies for HCC diagnosis and care

Published:2024-01 Issue:1 Volume:23 Page:
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:

Author:

Wang Allison E.¹^ORCID,Leven Emily A.²^ORCID,Grinspan Lauren T.³^ORCID,Villanueva Augusto⁴^ORCID

Affiliation:

1. Department of Medicine, Division of Gastroenterology, Mount Sinai Morningside-West, Icahn School of Medicine at Mount Sinai, New York, NY, USA

2. Department of Medicine, Division of Gastroenterology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA

3. Department of Medicine, Division of Liver Diseases, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

4. Department of Medicine, Divisions of Liver Disease and Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference20 articles.

1. Hepatocellular carcinoma surveillance – utilization, barriers and the impact of changing aetiology;Huang;Nat Rev Gastroenterol Hepatol,2023

2. Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?;Parikh;J Hepatol,2023

3. GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis;Singal;Hepatology,2022

4. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma;Singal;Hepatology,2023

5. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma;Galle;J Hepatol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP